CytoSorbents Stock (NASDAQ: CTSO) stock price, news, charts, stock research, profile.
Open | $0.880 |
Close | $0.810 |
Volume / Avg. | 170.060K / 101.762K |
Day Range | 0.801 - 0.926 |
52 Wk Range | 0.782 - 4.290 |
Market Cap | $45.617M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 2.94% |
Days to Cover | 17.34 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CytoSorbents (NASDAQ: CTSO) through any online brokerage.
Other companies in CytoSorbents’s space includes: Precision Optics Corp (NASDAQ:POCI), Pro-Dex (NASDAQ:PDEX), LENSAR (NASDAQ:LNSR), Autonomix Medical (NASDAQ:AMIX) and Modular Medical (NASDAQ:MODD).
The latest price target for CytoSorbents (NASDAQ: CTSO) was reported by HC Wainwright & Co. on Tuesday, May 7, 2024. The analyst firm set a price target for 1.00 expecting CTSO to rise to within 12 months (a possible 19.05% upside). 5 analyst firms have reported ratings in the last year.
The stock price for CytoSorbents (NASDAQ: CTSO) is $0.84 last updated May 9, 2024 at 5:07 PM EDT.
There are no upcoming dividends for CytoSorbents.
CytoSorbents’s Q2 earnings are confirmed for Tuesday, July 30, 2024.
There is no upcoming split for CytoSorbents.
CytoSorbents is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.